Chinese biotech firm Trinomab closes $104m pre-IPO round to advance product pipeline
The round was led by PE investment firm Kingray Capital and Gree Financial Investment.
Hong Kong Chen Leiwen Zhuhai Gree Group Jinhang Group Wuxi Guolian Development Asia Hillhouse Capital Group
Source: dealstreetasia.com